Plakous Therapeutics: Funding, Investors & Team (Sep 2026)
Plakous Therapeutics, a human biologics company that specializes in restorative and regenerative healing. The company advances in regenerative healing by manufacturing bio-therapeutics from the post-delivery human placenta. It establishes a safe and effective therapeutic platform to promote and sustain healing using the placental cytokines and growth factors that orchestrate fetal development and also allow the body to heal itself. Seth Tomblyn and Scott Washburn co-founded the company in 2016 and Headquartered in Winston Salem, North Carolina.
Plakous Therapeutics has raised $2.0M across 3 funding rounds on record, the most recent a Grant of $60k announced in Jul 2022.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Plakous Therapeutics Company Profile and Key Stats
Latest funding round on record: Jul 2022.
Plakous Therapeutics Funding Rounds
Plakous Therapeutics raised $1.5M in a Grant announced in Aug 2021.
7 months later, a Grant of $400k was announced in Mar 2022.
4 months later, a Grant of $60k was announced in Jul 2022.
Plakous Therapeutics Founders and Leadership Team
Contact details for the Plakous Therapeutics team: 1 of 2 have an email address on file.
Start 14-day free trial →Plakous Therapeutics Funding Compared to Other Biotechnology Startups
Plakous Therapeutics' latest round of $60k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Plakous Therapeutics in Biotechnology and Winston Salem
Companies Similar to Plakous Therapeutics
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Plakous Therapeutics Funding FAQs
What does Plakous Therapeutics do?
Plakous Therapeutics, a human biologics company that specializes in restorative and regenerative healing. The company advances in regenerative healing by manufacturing bio-therapeutics from the post-delivery human placenta. It establishes a safe and effective therapeutic platform to promote and sustain healing using the placental cytokines and growth factors that orchestrate fetal development and also allow the body to heal itself. Seth Tomblyn and Scott Washburn co-founded the company in 2016 and Headquartered in Winston Salem, North Carolina.
How much funding has Plakous Therapeutics raised?
Plakous Therapeutics has raised $2.0M across 3 rounds on record. The most recent is a Grant of $60k announced in Jul 2022.
When did Plakous Therapeutics last raise funding?
Plakous Therapeutics' most recent funding round on record is a Grant of $60k, announced in Jul 2022.
Who founded Plakous Therapeutics?
FundedIQ lists Scott Washburn (Founder) at Plakous Therapeutics.
Who is the CEO of Plakous Therapeutics?
Robert Boyce is listed as CEO at Plakous Therapeutics.
Where is Plakous Therapeutics headquartered?
Plakous Therapeutics is based in Winston Salem, North Carolina, United States.
How many employees does Plakous Therapeutics have?
Plakous Therapeutics is in the 1-10 employee band.
How does Plakous Therapeutics' funding compare to other Biotechnology startups?
Plakous Therapeutics' latest round of $60k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Plakous Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Plakous Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.